This scorecard represents results from the Department of Vermont Health Access' annual Consumer Assessment of Healthcare Providers and Systems (CAHPS) Medicaid Adult and Children surveys. Vermont Medicaid uses a nationally recognized experience of care survey tool, administered by a nationally certified vendor to a sample of both our adult and child beneficiaries. Most of the performance measures (PMs) listed below are composite measures.
A random sample of the Vermont Medicaid population is drawn each year for the CAHPS surveys. Respondents are asked to select their race from the standard survey categories. The adult and child results can be seen in the table below:
|Q: What is your race?||2020|
|Native American or Pacific Islander||0%||0%|
|American Indian or Alaska Native||4%||4%|
The voice of the customer is a critical element in the administration of the State Medicaid plans. Hearing from our customers provides us with useful information about what we're doing well and what we could be doing better. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey provides an assessment of health plan performance from a customer perspective.
The Department of Vermont Health Access' (DVHA) certified vendor administered this survey to parents/guardians of eligible child members 17 years of age and younger enrolled in Vermont's Medicaid managed care program, Dr. Dynasaur, via a mixed methodology (mail with telephone follow-up).
The Child with Chronic Conditions survey questions are a set of supplemental questions that can be added to the core Child Medicaid CAHPS survey. DVHA does not add this set of questions every year that we survey.
The CAHPS survey defines children with chronic conditions based on consequences rather than specific conditions or diseases: "Children with special health care needs are those who have a chronic physical, developmental, behavioral, or emotional condition and who also require health and related services of a type or amount beyond that generally required by children." Additionally, the duration of the condition is expected to be at least 12 months.